| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |